Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb:91:52-7.
doi: 10.1016/j.brainresbull.2013.01.003. Epub 2013 Jan 12.

Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake

Affiliations

Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake

Courtney Huff et al. Brain Res Bull. 2013 Feb.

Abstract

Recent studies have demonstrated that a preconditioning regimen (i.e., repeated low doses) of MDMA provides protection against the reductions in tissue concentrations of 5-HT and 5-HT transporter (SERT) density and/or expression produced by a subsequent binge regimen of MDMA. In the present study, the effects of preconditioning and binge treatment regimens of MDMA on SERT function were assessed by synaptosomal 5-HT uptake. Synaptosomal 5-HT uptake was reduced by 72% 7 days following the binge regimen (10 mg/kg, i.p. every 2 h for a total of 4 injections). In rats exposed to the preconditioning regimen of MDMA (daily treatment with 10 mg/kg for 4 days), the reduction in synaptosomal 5-HT uptake induced by a subsequent binge regimen was significantly less. Treatment with the preconditioning regimen alone resulted in a transient 46% reduction in 5-HT uptake that was evident 1 day, but not 7 days, following the last injection of MDMA. Furthermore, the preconditioning regimen of MDMA did not alter tissue concentrations of 5-HT, whereas the binge regimen of MDMA resulted in a long-term reduction of 40% of tissue 5-HT concentrations. The distribution of SERT immunoreactivity (ir) in membrane and endosomal fractions of the hippocampus also was evaluated following the preconditioning regimen of MDMA. There was no significant difference in the relative distribution of SERTir between these two compartments in control and preconditioned rats. The results demonstrate that SERT function is transiently reduced in response to a preconditioning regimen of MDMA, while long-term reductions in SERT function occur in response to a binge regimen of MDMA. Moreover, a preconditioning regimen of MDMA provides protection against the long-term reductions in SERT function evoked by a subsequent binge regimen of the drug. It is tempting to speculate that the neuroprotective effect of MDMA preconditioning results from a transient down-regulation in SERT function.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement:

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1. Effect of the preconditioning regimen on the subsequent MDMA-induced reduction in synaptosomal 5-HT uptake
Rats were treated with either the preconditioning regimen of MDMA (10 mg/kg i.p.) or vehicle once daily for four days. On the following day, the rats were injected with either the binge regimen of MDMA (10 mg/kg, i.p. at 2 h intervals for a total of 4 injections) or vehicle and were sacrificed seven days after the last injection by decapitation. The values represent the mean±SE of 5–8 rats. * represents p<0.001 when treatment groups are compared within the factor of prior exposure and # represents p<0.01 when compared to MDMA binge-treated rats previously exposed to vehicle.
Fig. 2
Fig. 2. Effect of the preconditioning regimen on synaptosomal uptake of 5-HT at 1 or 7days after the last injection of MDMA
Rats were treated with the preconditioning regimen of MDMA (10 mg/kg i.p.) or vehicle once daily for four days. Rats were sacrificed by decapitation either one or seven days after the last injection. The values represent the mean±SE of 7–11 rats. * represents p<0.01 when compared to the corresponding vehicle-treated group.
Fig. 3
Fig. 3. Comparison of the preconditioning and binge regimen of MDMA on tissue 5-HT concentrations in the hippocampus
Rats treated with the preconditioning regimen of MDMA (10 mg/kg i.p., once daily for four days) were sacrificed by decapitation either one (PC1) or seven days (PC7) after the last injection. Rats treated with binge regimen of MDMA (10 mg/kg, i.p. at 2 h intervals for a total of 4 injections) or vehicle were sacrificed seven days after the last injection. The values represent the mean±SE of 5–10 rats. * represents p<0.001 vs. the vehicle-treated group, as well as vs. the PC1 and PC7 groups.
Fig. 4
Fig. 4. Effect of the preconditioning regimen of MDMA on hippocampal plasma membrane (a and c) and endosome (b and d) SERT expression
Rats were treated with the preconditioning regimen of MDMA (10 mg/kg i.p.) or vehicle once daily for four days and were sacrificed one day after the last injection by decapitation. The values represent the mean±SE of 5–6 rats.

Similar articles

Cited by

References

    1. Aguirre N, Ballaz S, Lasheras B, Del Rio J. MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion. Eur. J. Pharmacol. 1998;346:181–188. - PubMed
    1. Asano S, Matsuda T, Nakasu Y, Maeda S, Nogi H, Baba A. Inhibition by nitric oxide of the uptake of [3H]serotonin into rat brain synaptosomes. Jpn. J. Pharmacol. 1997;75:123–128. - PubMed
    1. Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J. Pharmacol. Exp. Ther. 1987;242:911–916. - PubMed
    1. Bhide NS, Lipton JW, Cunningham JI, Yamamoto BK, Gudelsky GA. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain. Brain Res. 2009;1286:32–41. - PMC - PubMed
    1. Biezonski DK, Meyer JS. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. J. Neurochem. 2010;112:951–962. - PubMed

Publication types

MeSH terms

Substances